Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment

Abstract

The elevation of Abeta42 plasma levels in women with MCI may represent a biologic explanation for the sex-dependent increased incidence of late-onset AD in women identified by epidemiologic studies.